Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri and Reduced Bleeding on Probing (BOP)

Research synthesisLow evidenceMixed effect size4 studies · 3 beneficial · 1 neutral · 0 harmful

Across 4 studies, 3 reported beneficial effects of Lactobacillus reuteri on reducing bleeding on probing (BOP), with effect sizes ranging from small to moderate, while 1 study found no benefit. The predominant effect size is mixed (small to moderate). The most-studied dose was lozenges taken twice daily, though CFU counts were inconsistently reported. Effects were observed primarily in patients with periodontitis, and the median study duration across the 1 study reporting duration was 21 days, which is relatively short for periodontal outcomes.

  • Effective dose range: 2 lozenges/day (specific CFU not consistently reported)
  • Studied populations: Patients with periodontitis (stage III/IV, grade B/C) and adolescents with betel quid chewing habits

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. The only study with neutral findings was a 2025 RCT with a higher evidence score, suggesting the effect may be modest or context-dependent. Most trials were short (≤21 days), limiting generalizability to longer-term periodontal outcomes.

Generated May 25, 2026
Doses used in studies
  • day: 2 (median 2, IQR 22) 1 study
  • lozenges/day: 2 (median 2, IQR 22) 1 study
Time to effect
Median: 3 weeks · IQR 3 weeks3 weeks · Range 3 weeks3 weeks — Reported in 1 of 4 studies
4 of 4 papers
Back to top